nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—MAOA—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0596	0.0596	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0528	0.0528	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0303	0.0303	CbGpPWpGaD
Sumatriptan—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.0292	0.0292	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.027	0.027	CbGpPWpGaD
Sumatriptan—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.026	0.026	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.023	0.023	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—RHO—age related macular degeneration	0.0195	0.0195	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0181	0.0181	CbGpPWpGaD
Sumatriptan—MAOA—Melatonin metabolism and effects—APOE—age related macular degeneration	0.0175	0.0175	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0155	0.0155	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.0155	0.0155	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0132	0.0132	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-2-alpha transcription factor network—KDR—age related macular degeneration	0.0129	0.0129	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0129	0.0129	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0125	0.0125	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—RHO—age related macular degeneration	0.0124	0.0124	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—RHO—age related macular degeneration	0.0122	0.0122	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—RHO—age related macular degeneration	0.0118	0.0118	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00989	0.00989	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00968	0.00968	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—RHO—age related macular degeneration	0.00928	0.00928	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00861	0.00861	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00828	0.00828	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—RHO—age related macular degeneration	0.00815	0.00815	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00756	0.00756	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—RHO—age related macular degeneration	0.00753	0.00753	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00738	0.00738	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—RHO—age related macular degeneration	0.00737	0.00737	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00712	0.00712	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.00711	0.00711	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00708	0.00708	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—RHO—age related macular degeneration	0.00666	0.00666	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00648	0.00648	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00635	0.00635	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00635	0.00635	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—C3—age related macular degeneration	0.00629	0.00629	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00609	0.00609	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—RHO—age related macular degeneration	0.00604	0.00604	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RDH8—age related macular degeneration	0.00582	0.00582	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—CST3—age related macular degeneration	0.00577	0.00577	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00568	0.00568	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00564	0.00564	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—RHO—age related macular degeneration	0.00562	0.00562	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00543	0.00543	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00543	0.00543	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RPE65—age related macular degeneration	0.00509	0.00509	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00502	0.00502	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00502	0.00502	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.005	0.005	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—RHO—age related macular degeneration	0.00493	0.00493	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00481	0.00481	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RHO—age related macular degeneration	0.00426	0.00426	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NMNAT1—age related macular degeneration	0.00422	0.00422	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00418	0.00418	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RHO—age related macular degeneration	0.00417	0.00417	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ABCA4—age related macular degeneration	0.0041	0.0041	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—C3—age related macular degeneration	0.00402	0.00402	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—C3—age related macular degeneration	0.00394	0.00394	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00391	0.00391	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NMNAT1—age related macular degeneration	0.00391	0.00391	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.0039	0.0039	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RHO—age related macular degeneration	0.00386	0.00386	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—C3—age related macular degeneration	0.00381	0.00381	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RHO—age related macular degeneration	0.00378	0.00378	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RDH8—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ELOVL4—age related macular degeneration	0.00369	0.00369	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RDH8—age related macular degeneration	0.00365	0.00365	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NMNAT1—age related macular degeneration	0.00361	0.00361	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RHO—age related macular degeneration	0.00357	0.00357	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ELOVL4—age related macular degeneration	0.00342	0.00342	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00342	0.00342	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NMNAT1—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0033	0.0033	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RPE65—age related macular degeneration	0.00326	0.00326	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0032	0.0032	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RPE65—age related macular degeneration	0.00319	0.00319	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RHO—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ELOVL4—age related macular degeneration	0.00315	0.00315	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—C3—age related macular degeneration	0.003	0.003	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—CCL2—age related macular degeneration	0.00298	0.00298	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SLC16A8—age related macular degeneration	0.00297	0.00297	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00292	0.00292	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ELOVL4—age related macular degeneration	0.00292	0.00292	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RHO—age related macular degeneration	0.00288	0.00288	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RHO—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RDH8—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SLC16A8—age related macular degeneration	0.00275	0.00275	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00272	0.00272	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00272	0.00272	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00268	0.00268	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—C3—age related macular degeneration	0.00263	0.00263	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ABCA4—age related macular degeneration	0.00262	0.00262	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ABCA4—age related macular degeneration	0.00257	0.00257	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SLC16A8—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RHO—age related macular degeneration	0.00253	0.00253	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0025	0.0025	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00248	0.00248	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00246	0.00246	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00245	0.00245	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—C3—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RPE65—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—C3—age related macular degeneration	0.00238	0.00238	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SLC16A8—age related macular degeneration	0.00235	0.00235	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RHO—age related macular degeneration	0.00228	0.00228	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00226	0.00226	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—C3—age related macular degeneration	0.00215	0.00215	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00213	0.00213	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFBR1—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Sumatriptan—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—C3—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CCL2—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SQSTM1—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.00182	0.00182	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00181	0.00181	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CCL2—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—LIPC—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CETP—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—LIPC—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—C3—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CETP—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—LIPC—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CETP—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—C3—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—LIPC—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CETP—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—C3—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APOE—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KDR—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000978	0.000978	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000967	0.000967	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000957	0.000957	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000956	0.000956	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000932	0.000932	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCL2—age related macular degeneration	0.000903	0.000903	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000901	0.000901	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CD36—age related macular degeneration	0.000882	0.000882	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000867	0.000867	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000839	0.000839	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000818	0.000818	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CD36—age related macular degeneration	0.000817	0.000817	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—age related macular degeneration	0.000778	0.000778	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000761	0.000761	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CD36—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—C3—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000729	0.000729	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000723	0.000723	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—age related macular degeneration	0.000721	0.000721	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CD36—age related macular degeneration	0.000699	0.000699	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—age related macular degeneration	0.000687	0.000687	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KDR—age related macular degeneration	0.000673	0.000673	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000673	0.000673	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—age related macular degeneration	0.000666	0.000666	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000659	0.000659	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000651	0.000651	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.00064	0.00064	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CETP—age related macular degeneration	0.000628	0.000628	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—age related macular degeneration	0.000616	0.000616	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—age related macular degeneration	0.00058	0.00058	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCL2—age related macular degeneration	0.000578	0.000578	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000566	0.000566	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000551	0.000551	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000502	0.000502	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000483	0.000483	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.00045	0.00045	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000441	0.000441	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000431	0.000431	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD36—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000371	0.000371	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—age related macular degeneration	0.000333	0.000333	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000243	0.000243	CbGpPWpGaD
